Taaleri Bioindustry I
Overview
Taaleri Bioindustry I is a closed-end private equity fund that invests in industrial-scale production facilities and disruptive technologies within the bioindustry and circular economy sectors in Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Everox | Nov 2024 | Series A | Co-investor |
| Enifer | May 2024 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Vesa Heikkila
Founding Partner, Managing Director
Jorma Niemelä
Portfolio Manager (Real Estate)
Kati Salo
Portfolio Manager
Pertti Rokkila
investing manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Taaleri Bioindustry I based?
Taaleri Bioindustry I is headquartered in Helsinki, Finland.
When was Taaleri Bioindustry I founded?
Taaleri Bioindustry I was founded in 2021.
How many portfolio companies does Taaleri Bioindustry I have?
Taaleri Bioindustry I has 3 portfolio companies in Caplight's dataset.
What are some companies in Taaleri Bioindustry I's portfolio?
Portfolio companies visible on Caplight include Everox, Enifer.
What was Taaleri Bioindustry I's most recent investment shown here?
Taaleri Bioindustry I's most recent investment in this portfolio sample was in Everox in 2024.
What sectors does Taaleri Bioindustry I focus on?
Taaleri Bioindustry I focuses on Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Taaleri Bioindustry I focus on?
Stage focus information for Taaleri Bioindustry I is not publicly available.
What is Taaleri Bioindustry I's AUM?
Taaleri Bioindustry I's assets under management are estimated between $115.6M and $115.6M.